These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Nanofibrous poly(vinyl alcohol)/chitosan contained carbonated hydroxyapatite nanoparticles scaffold for bone tissue engineering.
    Author: Januariyasa IK, Ana ID, Yusuf Y.
    Journal: Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110347. PubMed ID: 31761152.
    Abstract:
    A scaffold that mimics the physicochemical structure of bone at the nanoscale level is an attractive alternative to conventional bone grafts, but its development remains a main challenge in bone tissue engineering today. This work describes the fabrication of a nanofibrous poly(vinyl alcohol)/chitosan/carbonated hydroxyapatite (PVA/CS/CHAp) scaffold. CHAp nanoparticles were synthesized using a co-precipitation method, and nanofibrous PVA/CS/CHAp scaffolds were fabricated by electrospinning using CHAp concentrations of 0, 5, 10, 15, and 20 wt%. The physicochemical properties of the scaffolds were evaluated by SEM, XRD, FTIR, and EDS, and the mechanical properties were determined by tensile strength tests. Swelling behavior, protein adsorption onto the scaffold surfaces, surface biomineralization, and cells viability were also evaluated in vitro. The addition of CHAp to the composite decreased the fiber diameter from ∼160 nm at 0 wt% to ∼139 nm at 15 wt% and great agglomerations were evident at 20 wt%. XRD, FTIR, and EDS showed effective incorporation of CHAp into the nanofibrous structure. This CHAp incorporation significantly increased the modulus of the scaffold at PVA/CS/CHAp 15 wt%, with an average 103.86 MPa, but tensile strength was not significantly altered. However, the elongation at break was decreased as the CHAp concentration increased. Swelling capacity of scaffold increases due to CHAp addition. Protein adsorption onto the scaffold increased 2.3fold at 20 wt% when compared to 0 wt%. The PVA/CS/CHAp 15 wt% showed a better bioactivity when compared to PVA/CS/CHAp 0 wt% after immersion of the scaffolds in a simulated body fluid solution for 7 days. Cell viability and cell morphology results reveal that PVA/CS/CHAp able to facilitate osteoblast cells to attach and proliferate. Introducing higher CHAp into the scaffold could increase the cell viability of the scaffold. PVA/CS/CHAp has potential to serve as an alternative scaffold material for bone tissue engineering.
    [Abstract] [Full Text] [Related] [New Search]